An Argus II Case Report

Perente, İrfan; Erdoğan, Gürkan; Taşkapılı, Muhittin

Online Makale

Online Hizmetlere Toplu Bakış Online Kayıt ve Konaklama Online Bilimsel Program Dernekler İçin... Referanslarımız Telefon ve e-posta Desteği Bildiri özeti nedir? Bildiri özeti nasıl hazırlanır? Bildiri özeti örnekleri Kabul mektubu örnekleri

Beyoglu Eye Journal

An Argus II Case Report [Beyoglu Eye J]

Beyoglu Eye J. 2017; 2(1): 33-37 | DOI: 10.14744/bej.2017.54264

An Argus II Case Report

İrfan Perente, Gürkan Erdoğan, Muhittin Taşkapılı
University of Health Sciences Beyoglu Eye Training and Research Hospital, Istanbul, Turkey

The Argus II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA, USA) is the first US Food and Drug Administration-approved retinal implant. It provides electrical stimulation of the retina and induces visual perception in individuals with low vision. It is used in patients with severe disease, such as retinitis pigmentosa (RP). Presently described is Argus II implantation in a patient with RP.

Keywords: Argus 2, retinal implant, retinitis pigmentosa.

İrfan Perente, Gürkan Erdoğan, Muhittin Taşkapılı. An Argus II Case Report. Beyoglu Eye J. 2017; 2(1): 33-37

Corresponding Author: İrfan Perente, Türkiye

TOOLS

Full Text PDF

Print

Download citation

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

Share with email

Share

Send email to author

Similar articles

PubMed

Google Scholar